Understanding Hypoglycemia and its Implications

This module explains the importance of identifying the risk of diabetes in asymptomatic patients to prevent the development of complications. It focuses on laboratory analyses used for the diagnosis of diabetes mellitus and explains why glycated hemoglobin is the most used indicator of glycemic control. The module aims to provide insight into understanding glycemic variability and the concept of time in range and their relevance to the management of diabetes.

This comprehensive learning module is designed to strengthen the understanding and clinical management of cardiometabolic syndrome, a complex and increasingly prevalent health condition. Through evidence-based insights, this module explores the pathophysiology, epidemiology, and diagnostic criteria of cardiometabolic syndrome, and addresses its significant impact on public health. Emphasis is placed on cardiovascular risk assessment, prevention strategies, and the latest management guidelines in patients with type 2 diabetes. Through interactive case discussion, healthcare professionals are equipped with the tools to deliver a patient-centred and multidisciplinary approach to managing cardiometabolic risk and its complications.

This module offers an immersive learning experience through three speaker talks and an AI-powered clinical case simulation. It highlights the critical importance of early glycemic control in patients with diabetes mellitus to prevent cardiovascular complications. The focus is on the 2019 European Society of Cardiology (ESC) guidelines on diabetes, pre-diabetes, and cardiovascular diseases. The module specifically explores the reclassification of cardiovascular risk in diabetes and introduces novel treatment algorithms utilizing glucose-lowering agents for the prevention and management of cardiovascular disease. Furthermore, the concept is reinforced through a real-world practice based clinical case study.

Online learning program with clinical cases for practical knowledge.

The webinar aimed to address the challenges associated with managing both pre-pregnancy diabetes and gestational diabetes. The session emphasized critical aspects of pre-conception pregnancy preparation for women with diabetes, stressing the need for accurate methods in classifying, screening, and diagnosing gestational diabetes to prevent adverse outcomes for both mothers and foetuses. Furthermore, the webinar highlighted the crucial role of insulin therapy when medical nutrition therapy or lifestyle modification becomes challenging for achieving optimal glycaemic control. It also underscored the importance of postpartum care and support, providing personalized recommendations for ongoing care based on individual needs. The event concluded with an engaging Q&A session, enhancing the depth of insights shared throughout the webinar.

This educational module equips healthcare professionals with the latest evidence and clinical strategies for managing type 2 diabetes effectively. It delves into the pathophysiology, epidemiology, diagnostic criteria, and risk factors that define the global and local burden of diabetes. The course integrates both international standards and region-specific guidelines (e.g., DEMSoG and EADSG) to support context-relevant care. Through detailed exploration of pharmacologic options and patient-centred management, learners will be empowered to deliver effective, individualized, and multidisciplinary diabetes care.

This module discusses the epidemiology and pathophysiology of hypoglycemia. It discusses the prevalence of hypoglycemia across all age groups and the need to focus on patient education and counselling to prevent recurrent episodes of hypoglycemia. It focuses on diabetic ketoacidosis as the leading cause of emergencies in patients with Type 2 diabetes and its effective prevention and management. Additionally, the module brings attention to Hyperosmolar Hyperglycemic State (HHS), and its underlying multifactorial physiology that requires appropriate multifactorial intervention to prevent and manage patients with type 2 diabetes. It is of particular significance to differentiate between HHS and Diabetic Ketoacidosis (DKA).

Online learning program with clinical cases for practical knowledge.

Live webinar for Principles of diabetes management, Timely initiation of insulin in type 2 diabetes– French speaking healthcare professionals.

This module discusses the prevalence of comorbidities and complications associated with diabetes and the risk factors specific to the sub-Saharan Africa region. It explains how the transition from pre-diabetes to type 2 diabetes occurs and how early diagnosis and intervention can prevent the development of vascular complications. Additionally, the video explains the connection between obesity and diabetes. It highlights the importance of ectopic fat in causing type 2 diabetes and its link to cardiovascular risk factors. It also focuses on the timing of diabetes onset and its implications on cardiovascular risk.

This module focuses on the intricate relationship among the cardiovascular, renal, and metabolic (CRM) systems, and their significance in individuals diagnosed with Type 2 Diabetes (T2D). The course highlights Diabetic Nephropathy and its complex underlying physiology influenced by various factors, necessitating a comprehensive approach to intervention for the prevention and treatment of patients. Furthermore, the module elucidates the best practices for managing individuals with type 2 diabetes who are at risk of cardiorenal complications, while also providing an up-to-date overview of the current EASD/ADA and KDIGO Guidelines.

The module offers an overview of the East Africa Diabetes Study Group (EADSG) insulin therapy guidelines in type 1 diabetes (T1D) and the latest advancements in its management. With a particular focus on safety and efficacy, the individualization of glycemic targets based on education and socio-economic status have been explored in depth. Moreover, the significance of assessing available resources for managing hypoglycaemia with specific insulin types, while also emphasizing the position of advancements in T1D therapy has been effectively highlighted.